ALA 1.61% 15.3¢ arovella therapeutics limited

Ann: FY20 Annual Report to shareholders, page-16

  1. 362 Posts.
    lightbulb Created with Sketch. 278
    Not a great way to endear yourself to the shareholders of the company you just took leadership of right? I don’t even know how you can feel comfortable taking a bonus of that magnitude for a 40% SP decline performance.

    At the very least reinvest it and buy some bloody stock in your own company.

    Michael Baker, CEO Suda Pharmaceuticals. Total shares owned: Zero.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
15.3¢
Change
-0.003(1.61%)
Mkt cap ! $160.3M
Open High Low Value Volume
15.5¢ 15.5¢ 15.0¢ $82.79K 539.5K

Buyers (Bids)

No. Vol. Price($)
1 18124 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 108897 1
View Market Depth
Last trade - 15.46pm 12/07/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.